logo
Select company
Select metric
-164.32%Return on Equity
VS
Market
8
Sector
22
Industry
27
History
56
$ 12.4Close
$ 6.3 - $ 178.5 52-Week Range
Ticker Information

Ticker

BCTX

Company Name

BRIACELL THERAPEUTICS CORP

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

BRIACELL THERAPEUTICS CORP - Return on Equity Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

BCTX - ROE Historical data
DateShareholders EquityNet Income Common StockReturn on Equity
3/31/2025$ 11.94M$ -19.62M-164.32%
12/31/2024$ 3.23M$ -11.78M-365.01%
9/30/2024$ 3.71M$ -16.77M-451.78%
6/30/2024$ -2.38M$ -4.93M0%
3/31/2024$ -5.97M$ -6.04M0%
12/31/2023$ -8.07M$ -12.65M0%
9/30/2023$ 2.52M$ -13.19M-524.35%
6/30/2023$ -3.78M$ -20.3M0%
3/31/2023$ -5.89M$ -36.18M0%
12/31/2022$ -1.28M$ -35.01M0%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Definition of Return on Equity

[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].
Net Inc. Cmn. / Equity
(=) ROE
ROE for BRIACELL THERAPEUTICS CORP is calculated as follows: Net Inc. Cmn. [ $ -3.81M ] / Equity [ $ -3.4M ]
(=) ROE [ 0% ]

BCTX - Return on Equity, Last 5 years

-524.35%

Minimum

Sep 30, 2023

-0.75%

Maximum

Jun 30, 2021

-206.66%

Average

-208.47%

Median

ROE Benchmark Analysis

The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
filtered constituents3.13K
min-66.24%
max73.25%
average1.63%
median6.53%
std22.52%